Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia-Reference-Cited by-同舟云学术

Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia

Published:2014-07-26 Issue:3 Volume:167 Page:356-365
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Benton Christopher B.¹,Thomas Deborah A.²,Yang Hui²,Ravandi Farhad²,Rytting Michael³,O'Brien Susan²,Franklin Anna R.³,Borthakur Gautam²,Dara Samuel²,Kwari Monica²,Pierce Sherry R.²,Jabbour Elias²,Kantarjian Hagop²,Garcia-Manero Guillermo²

Affiliation:

1. Division of Cancer Medicine; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Pediatrics; The University of Texas MD Anderson Cancer Center; Houston TX USA

Funder

National Institutes of Health

Leukemia & Lymphoma Society

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13050/fullpdf

Reference39 articles.

1. Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors;Appleton;Journal of Clinical Oncology,2007

2. DNA methylation and gene silencing in cancer;Baylin;Nature Clinical Practice Oncology,2005

3. Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine;Blum;Proceedings of the National Academy of Sciences of the United States of America,2010

4. Epigenetics of haematopoietic cell development;Cedar;Nature Reviews Immunology,2011

5. Wnt/beta-catenin signaling in development and disease;Clevers;Cell,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients;Leukemia Research;2024-10

2. Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature;Leukemia & Lymphoma;2024-08-14

3. Investigates the genetic types of acute lymphoblastic leukemia in full remission Indonesian patients: a cross-sectional analysis;American Journal of BioMedicine;2024-04-11

4. The landscape of alterations affecting epigenetic regulators in T‐cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities;International Journal of Cancer;2023-12-28

5. Drug-induced hyperglycemia and diabetes;Therapies;2023-10